Mr. Chair, we are thrilled to have contracts with seven of the most promising vaccines in the world. Indeed, it has been wise advice from the vaccine task force to have a diverse portfolio, because, of course, some of these are still in development. The three most promising, however, are actually in the regulatory approval process and working very closely with Health Canada to ensure we have the data needed to assess their safety.
In the House of Commons on November 26th, 2020. See this statement in context.